Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement

被引:48
作者
Borot, S. [1 ,2 ]
Benhamou, P. Y. [3 ]
Atlan, C. [4 ]
Bismuth, E. [5 ]
Bonnemaison, E. [6 ]
Catargi, B. [7 ]
Charpentier, G. [8 ]
Farret, A. [9 ,10 ,11 ]
Filhol, N. [12 ]
Franc, S. [13 ,14 ]
Gouet, D. [15 ]
Guerci, B. [16 ]
Guilhem, I. [17 ]
Guillot, C. [18 ]
Jeandidier, N. [19 ]
Joubert, M. [20 ]
Melki, V. [21 ]
Merlen, E. [22 ]
Penfornis, A. [23 ]
Picard, S. [24 ]
Renard, E.
Reznik, Y. [19 ]
Riveline, J. P. [23 ]
Rudoni, S. [24 ]
Schaepelynck, P. [12 ]
Sola-Gazagnes, A. [25 ]
Tubiana-Rufi, N. [5 ]
Verier-Mine, O. [26 ]
Hanaire, H. [20 ]
机构
[1] Besancon Univ Hosp, Dept Endocrinol Nutr & Diabet, F-25030 Besancon, France
[2] Franche Comte Univ, F-25030 Besancon, France
[3] Grenoble Alpes Univ, Grenoble Univ Hosp, Dept Diabetol, Pole DigiDune, F-38700 La Tronche, France
[4] Luxembourg Hosp, Dept Endocrinol, L-1210 Luxembourg, Luxembourg
[5] Robert Debre Hosp, AP HP, Dept Pediat Endocrinol & Diabetol, F-75019 Paris, France
[6] Tours Univ Hosp, Dept Pediat Med, F-37044 Tours, France
[7] Bordeaux Univ Hosp, Dept Endocrinol & Diabet, F-33000 Bordeaux, France
[8] Ctr Study & Res Improvement Treatment Diabet CERI, F-91058 Evry, France
[9] Montpellier Univ Hosp, Dept Endocrinol, F-34090 Montpellier, France
[10] Montpellier Univ Hosp, UMR CNRS, F-34090 Montpellier, France
[11] Univ Montpellier, F-34090 Montpellier, France
[12] Marseille Univ Hosp, Dept Diabetol, F-13005 Marseille, France
[13] Sud Francilien Hosp, Dept Diabetol, F-91110 Corbeil Essonnes, France
[14] La Rochelle Gen Hosp, Dept Diabetol, F-17000 La Rochelle, France
[15] Nancy Univ Hosp, Dept Endocrinol Diabetol Metab Dis & Nutr, F-54500 Vandoeuvre Les Nancy, France
[16] Rennes Univ Hosp, Dept Endocrinol & Diabetol, F-35200 Rennes, France
[17] French Diabet Federat, Diabet LAB, F-75011 Paris, France
[18] Strasbourg Univ Hosp, Dept Endocrinol & Diabetol, F-67091 Strasbourg, France
[19] Caen Univ Hosp, Dept Endocrinol & Diabetol, F-14033 Caen, France
[20] Toulouse Univ Hosp, Dept Diabetol, F-31400 Toulouse, France
[21] Lille Univ Hosp, Dept Endocrinol, F-59000 Lille, France
[22] Point Med Dijon, Dijon, France
[23] Univ Paris 07, Lariboisiere Hosp, AP HP, Dept Diabet & Endocrinol, F-75475 Paris, France
[24] Dijon Univ Hosp, Dept Endocrinol Diabet & Metab Dis, F-21000 Dijon, France
[25] Cochin Hosp, AP HP, Dept Diabet, F-75014 Paris, France
[26] Valencienne Gen Hosp, Dept Diabet, F-59300 Valenciennes, France
关键词
Continuous glucose monitoring; Flash glucose monitoring; Guidelines; Patient education; Subcutaneous insulin infusion; Type; 1; diabetes; 2; INSULIN PUMP THERAPY; GLYCEMIC CONTROL; BLOOD-GLUCOSE; SENSING TECHNOLOGY; TYPE-1; CHILDREN; HYPOGLYCEMIA; TIME; INTERRUPTION; ADOLESCENTS;
D O I
10.1016/j.diabet.2017.10.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The use by diabetes patients of real-time continuous interstitial glucose monitoring (CGM) or the FreeStyle Libre (R) (FSL) flash glucose monitoring (FGM) system is becoming widespread and has changed diabetic practice. The working group bringing together a number of French experts has proposed the present practical consensus. Training of professionals and patient education are crucial for the success of CGM. Also, institutional recommendations must pay particular attention to the indications for and reimbursement of CGM devices in populations at risk of hypoglycaemia. The rules of good practice for CGM are the precursors of those that need to be enacted, given the oncoming emergence of artificial pancreas devices. It is necessary to have software combining user-friendliness, multiplatform usage and average glucose profile (AGP) presentation, while integrating glucose and insulin data as well as events. Expression of CGM data must strive for standardization that facilitates patient phenotyping and their follow-up, while integrating indicators of variability. The introduction of CGM involves a transformation of treatment support, rendering it longer and more complex as it also includes specific educational and technical dimensions. This complexity must be taken into account in discussions of organization of diabetes care. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:61 / 72
页数:12
相关论文
共 57 条
  • [1] [Anonymous], 2017, DIABETES TECHNOL S1
  • [2] [Anonymous], CLIN DIAB ENDOC
  • [3] [Anonymous], MED MAL METABOL
  • [4] [Anonymous], MED MAL METABOL
  • [5] The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
    Bailey, Timothy
    Bode, Bruce W.
    Christiansen, Mark P.
    Klaff, Leslie J.
    Alva, Shridhara
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (11) : 787 - 794
  • [6] Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study)
    Bajaj, Harpreet S.
    Venn, Karri
    Ye, Chenglin
    Patrick, Avril
    Kalra, Shivani
    Khandwala, Hasnain
    Aslam, Nadeem
    Twum-Barima, David
    Aronson, Ronnie
    [J]. DIABETES CARE, 2017, 40 (02) : 194 - 200
  • [7] Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study
    Basu, Ananda
    Veettil, Sona
    Dyer, Roy
    Peyser, Thomas
    Basu, Rita
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : 43 - 47
  • [8] The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
    Battelino, T.
    Conget, I.
    Olsen, B.
    Schuetz-Fuhrmann, I.
    Hommel, E.
    Hoogma, R.
    Schierloh, U.
    Sulli, N.
    Bolinder, J.
    [J]. DIABETOLOGIA, 2012, 55 (12) : 3155 - 3162
  • [9] Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
    Battelino, Tadej
    Phillip, Moshe
    Bratina, Natasa
    Nimri, Revital
    Oskarsson, Per
    Bolinder, Jan
    [J]. DIABETES CARE, 2011, 34 (04) : 795 - 800
  • [10] Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial
    Beck, Roy W.
    Riddlesworth, Tonya
    Ruedy, Katrina
    Ahmann, Andrew
    Bergenstal, Richard
    Haller, Stacie
    Kollman, Craig
    Kruger, Davida
    McGill, Janet B.
    Polonsky, William
    Toschi, Elena
    Wolpert, Howard
    Price, David
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04): : 371 - 378